Personalized Immunotherapy in Adults With Advanced Cancers Immunotherapy in Adults With Advanced Cancers

• Status: Active, not recruiting
• Trial end date: 2023-08-01

Summary

The purpose of this study is to determine if it is possible to make and administer safely a 'personalized' vaccine to treat patients that have been diagnosed with advanced cancer and are not candidates for curative therapy.

• Phase: Phase 1

Details

• Lead Sponsor: Ezra Cohen
• Treatments: Pembrolizumab; Vaccines